Risks of noncardiac surgery early after percutaneous coronary intervention

被引:16
|
作者
Smilowitz, Nathaniel R. [1 ,2 ]
Lorin, Jeffrey [1 ,2 ]
Berger, Jeffrey S. [1 ,3 ]
机构
[1] NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY USA
[2] Vet Affairs New York Harbor Hlth Care Syst, Dept Med, Div Cardiol, New York, NY USA
[3] NYU, Sch Med, Dept Surg, New York, NY USA
基金
美国国家卫生研究院;
关键词
DRUG-ELUTING STENTS; ADVERSE CARDIAC EVENTS; PERIOPERATIVE MANAGEMENT; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; CARDIOVASCULAR RISK; 30-DAY MORTALITY; TROPONIN LEVELS; ASSOCIATION; REVASCULARIZATION;
D O I
10.1016/j.ahj.2019.07.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Prior registry data suggest that 4%-20% of patients require noncardiac surgery (NCS) within 2 years of percutaneous coronary intervention (PCI). Contemporary data on NCS after PCI in the United States among women and men are limited. We determined the rate of early hospital readmission for NCS and associated outcomes in a large cohort of patients who underwent PCI in the United States. Methods Adults undergoing PCI between January 1 and June 30, 2014, were identified from the Nationwide Readmission Database. Patients readmitted for NCS within 6 months of PCI were identified. Outcomes of interest were inhospital death, myocardial infarction (MI), and bleeding defined by international Classification of Diseases, Ninth Revision, codes. Results Among 221,379 patients who underwent PCI and survived to hospital discharge, 3.5% (n = 7,696) were readmitted for NCS within 6 months post-PCI, and 41% of these hospitalizations were elective. Early NCS was complicated by MI in 4.7% of cases, and 21% of perioperative MIs were fatal. Bleeding was recorded in 32.0% of patients. All-cause mortality occurred in 4.4% of patients (n = 339) readmitted for surgery. The risk of death or MI was greatest when NCS was performed within the first month after PCI. Conclusions Despite clear guidelines to avoid surgery early after PCI, NCS was performed in 1 of every 29 patients with recent PCI, corresponding to as many as similar to 30,000 patients each year nationwide. Surgical mortality and perioperative MI were high in this setting. Strategies to minimize perioperative thrombotic and bleeding risks during readmission for NCS after PCI are necessary.
引用
收藏
页码:64 / 71
页数:8
相关论文
共 50 条
  • [1] Noncardiac Surgery and Bleeding After Percutaneous Coronary Intervention
    To, Andrew C. Y.
    Armstrong, Guy
    Zeng, Irene
    Webster, Mark W. I.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (03) : 213 - 221
  • [2] Noncardiac surgery following percutaneous coronary intervention
    Mendoza, CE
    Virani, SS
    Shah, N
    Ferreira, AC
    de Marchena, E
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2004, 63 (03) : 267 - 273
  • [3] Risks of noncardiac surgery after coronary stenting
    Reddy, PR
    Vaitkus, PT
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (06): : 755 - 757
  • [4] Outcomes After Noncardiac Surgery Performed Within 2 Years of Percutaneous Coronary Intervention
    Butala, Neel M.
    Hebbe, Annika
    Shah, Binita
    Smilowitz, Nathaniel R.
    Aijaz, Bilal
    Uzendu, Anezi
    Boulos, Peter
    Waldo, Stephen W.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (06):
  • [5] Prediction of Cardiac and Noncardiac Mortality After Percutaneous Coronary Intervention
    Spoon, Daniel B.
    Lennon, Ryan J.
    Psaltis, Peter J.
    Prasad, Abhiram
    Holmes, David R., Jr.
    Lerman, Amir
    Rihal, Charanjit S.
    Gersh, Bernard J.
    Ting, Henry H.
    Singh, Mandeep
    Gulati, Rajiv
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (09)
  • [6] Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents
    Rabbitts, Jennifer A.
    Nuttall, Gregory A.
    Brown, Michael J.
    Hanson, Andrew C.
    Oliver, William C.
    Holmes, David R.
    Rihal, Charanjit S.
    ANESTHESIOLOGY, 2008, 109 (04) : 596 - 604
  • [7] Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery
    Graham, Michelle M.
    Sessler, Daniel I.
    Parlow, Joel L.
    Biccard, Bruce M.
    Guyatt, Gordon
    Leslie, Kate
    Chan, Matthew T. V.
    Meyhoff, Christian S.
    Xavier, Denis
    Sigamani, Alben
    Kumar, Priya A.
    Mrkobrada, Marko
    Cook, Deborah J.
    Tandon, Vikas
    Alvarez-Garcia, Jesus
    Villar, Juan Carlos
    Painter, Thomas W.
    Landoni, Giovanni
    Fleischmann, Edith
    Lamy, Andre
    Whitlock, Richard
    Le Manach, Yannick
    Aphang-Lam, Meylin
    Cata, Juan P.
    Gao, Peggy
    Terblanche, Nicolaas C. S.
    Ramana, Pamidimukkala V.
    Jamieson, Kim A.
    Bessissow, Amal
    Mendoza, Gabriela R.
    Ramirez, Silvia
    Diemunsch, Pierre A.
    Yusuf, Salim
    Devereaux, P. J.
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (04) : 237 - +
  • [8] Overlap in Age at the Time of Elective Percutaneous Coronary Intervention and at Noncardiac Surgery
    Smilowitz, Nathaniel R.
    Berger, Jeffrey S.
    Beckman, Joshua A.
    Bangalore, Sripal
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : 1554 - 1555
  • [9] Percutaneous coronary intervention before noncardiac surgery: More threat than benefit?
    Mendoza, CE
    Shah, N
    Virani, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (04) : 713 - 714
  • [10] Incidence and outcomes of early percutaneous coronary intervention after isolated valve surgery
    Alqahtani, Fahad
    Ziada, Khaled
    Rihal, Charanjit S.
    Alkhouli, Mohamad
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 93 (04) : 583 - 589